Table 3.
PedGenie 2.1 | |||||||||||||
NARAC Study 1a | NARAC Study 2b | Meta-analysis | Previously publishedc | ||||||||||
PTPN22 | Genotyped | OR | 95% CI | p-trende | OR | 95% CI | p-trende | OR | 95% CI | p-trendf | OR | 95% CI | p-trend |
rs3789604 | AC | 0.94 | 0.69–1.26 | 1.16 | 0.93–1.46 | 1.07 | 0.91–1.26 | 1.15 | 0.93–1.42 | ||||
CC | 1.68 | 0.83–3.38 | 0.39 | 1.25 | 0.70–2.21 | 0.18 | 1.43 | 0.93–2.18 | 0.12 | 1.78 | 1.13–2.79 | 0.014 | |
rs1217413 | TC | 1.44 | 1.11–1.87 | 1.34 | 1.08–1.66 | 1.38 | 1.17–1.63 | ||||||
CC | 1.71 | 1.06–2.75 | 0.003 | 1.52 | 1.00–2.31 | 0.002 | 1.59 | 1.14–2.22 | <0.001 | ||||
rs1217388 | TC | 1.49 | 1.14–1.93 | 1.30 | 1.05–1.61 | 1.37 | 1.15–1.63 | ||||||
CC | 1.30 | 0.78–2.17 | 0.017 | 1.27 | 0.86–1.87 | 0.026 | 1.28 | 0.94–1.74 | 0.003 | ||||
ss38346943 | TC | 0.32 | 0.15–0.69 | 0.88 | 0.48–1.61 | 0.61 | 0.39–0.95 | ||||||
CC | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||||
rs1310182 | CT | 1.55 | 1.13–2.13 | 1.39 | 1.11–1.73 | 1.45 | 1.20–1.75 | 1.22 | 0.98–1.77 | ||||
TT | 1.57 | 1.07–2.30 | 0.011 | 1.62 | 1.18–2.22 | <0.01 | 1.60 | 1.25–2.03 | <0.001 | 1.32 | 0.97–1.54 | 0.052 | |
rs2476601 | CT | 1.92 | 1.41–2.60 | 2.36 | 1.84–3.04 | 2.18 | 1.80–2.65 | 2.19 | 1.73–2.78 | ||||
(R620W) | TT | 1.96 | 0.74–5.21 | <0.001 | 2.91 | 1.26–6.74 | <0.001 | 2.53 | 1.32–4.84 | <0.001 | 2.90 | 1.37–6.18 | <0.001 |
rs12730735 | AG | 1.00 | 0.75–1.31 | 1.10 | 0.89–1.36 | 1.06 | 0.89–1.25 | ||||||
GG | 0.48 | 0.29–0.80 | 0.08 | 0.56 | 0.37–0.83 | 0.14 | 0.53 | 0.39–0.72 | 0.024 | ||||
rs12760457 | AG | 1.01 | 0.75–1.36 | 1.09 | 0.87–1.37 | 1.06 | 0.89–1.26 | ||||||
GG | 0.48 | 0.28–0.82 | 0.09 | 0.55 | 0.37–0.82 | 0.14 | 0.52 | 0.38–0.72 | 0.023 | ||||
rs2488458 | GA | 1.51 | 1.15–1.97 | 1.33 | 1.07–1.66 | 1.40 | 1.18–1.67 | ||||||
AA | 1.27 | 0.79–2.05 | 0.014 | 1.20 | 0.81–1.78 | 0.037 | 1.23 | 0.91–1.67 | 0.003 | ||||
rs1217414 | CT | 1.02 | 0.77–1.35 | 0.85 | 0.69–1.04 | 0.91 | 0.78–1.06 | ||||||
TT | 0.60 | 0.34–1.03 | 0.20 | 0.70 | 0.46–1.06 | 0.053 | 0.65 | 0.46–0.92 | 0.018 |
aProblem 2 data, 446 family cases and 103 family controls in 202 affected NARAC pedigrees, 664 independent NYC controls; excludes Plenge et al. [6] samples.
bProblem 2 data, samples in Plenge et al. [6] candidate gene file, 839 family cases in 463 pedigrees and 854 independent NYC controls.
cCarlton et al. [5] sample set 2, 661 random independent cases from NARAC pedigrees and 1322 NYC controls; adjusted for R620W or rs3789604 (R620W).
dMinor allele heterozygote and homozygote genotypes according to Carlton et al. [5] Table 1.
eEmpirical confidence intervals and chi-square p-values, 1000 simulations; p < 0.05 in bold.
fEmpirical confidence intervals and CMH chi-square trend test p-values, 1000 simulations; p < 0.05 in bold.